Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study

Riccardo Mei, Lukas Kessler, Kim M. Pabst, Manuel Weber, Christian Schmidkonz, Christoph Rischpler, Helle Damgaard Zacho, Thomas Hope, Sarah M. Schwarzenböck, Martin Allen-Auerbach, Louise Emmett, Justin Ferdinandus, Marcus Unterrainer, Benedikt M. Schaarschmidt, Lale Umutlu, Andrea Farolfi, Paolo Castellucci, Cristina Nanni, Silvi Telo, Stefano Fanti, Ken Herrmann and Wolfgang P. Fendler
Journal of Nuclear Medicine July 2023, 64 (7) 1043-1048; DOI: https://doi.org/10.2967/jnumed.122.265245
Riccardo Mei
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukas Kessler
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim M. Pabst
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Weber
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Schmidkonz
4Department of Nuclear Medicine, University Hospital Erlangen, Erlangen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Rischpler
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helle Damgaard Zacho
5Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hope
6Department of Radiology and Biomedical Imaging, University of California, San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah M. Schwarzenböck
7Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Allen-Auerbach
8Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
9Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
10Department of Theranostics and Nuclear Medicine, St. Vincent’s Hospital, and Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Ferdinandus
11Department of Internal Medicine I, University of Cologne, Cologne, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Unterrainer
12Department of Radiology, University Hospital LMU Munich, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benedikt M. Schaarschmidt
13Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Umutlu
13Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Farolfi
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Castellucci
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Nanni
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvi Telo
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Fanti
2Nuclear Medicine Department, IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang P. Fendler
1Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
3German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Interobserver agreement by primary tumor (T), local nodal involvement (N), distant metastasis (M), and experience level (high, intermediate, and low).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Example cases and lesions (arrows) with high agreement, high disagreement, and mixed agreement with SOR. Maximum intensity projections (MIPs) are represented above, and fused transaxial PET/CT images are represented below. (A) Patient with local relapse of urothelial cancer confirmed by histopathology; 7 readers rated positive (2 high, 3 intermediate, 2 low experience), and 8 readers rated lesion negative (3 high, 2 intermediate, 3 low experience). (B) Patient with ovarian cancer; all readers agreed with expert on peritoneal involvement. (C) All readers agreed with expert on liver metastasis in patient with colorectal carcinoma. (D) All readers correctly identified diverticulosis in sarcoma patient. (E) Patient with urothelial cancer and retroperitoneal fibrosis; all readers falsely rated retroperitoneal lesions as malignant and disagreed with expert panel and histopathology.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Patient Characteristics (n = 50)

    CharacteristicData
    Age (y)
     Mean58 (SD, 16)
     Median61 (range, 19, 83)
    Sex
     Female23 (46.0%)
     Male27 (54.0%)
    Indication
     Initial staging21 (42.0%)
     Restaging29 (58.0%)
    Tumor stage
     No tumor8 (16.0%)
     Local10 (20.0%)
     Local nodal metastatic4 (8.0%)
     Metastatic (organ and bone)28 (56.0%)
    • Data are number followed by percentage in parentheses, except for age.

    • View popup
    TABLE 2.

    Interobserver Agreement on Visual Image Interpretation

    CategoryAgreement
    level
    Mean κInferior
    95% CI
    Superior
    95% CI
    THigh0.7090.7050.710
    Intermediate0.7290.7270.732
    Low0.5740.5720.577
    Any0.5630.4900.633
    NHigh0.6160.6130.619
    Intermediate0.5480.5460.551
    Low0.5130.5100.516
    Any0.5470.4720.616
    MHigh0.7490.7460.752
    Intermediate0.6470.6450.650
    Low0.5350.5320.538
    Any0.6860.6140.757
    • View popup
    TABLE 3.

    Sensitivity and Specificity for Observer with High, Intermediate, and Low Experience and for All Observers

    CategoryAgreement
    level
    SESPPPVNPVACC
    THigh0.910.630.810.790.81
    Intermediate0.890.730.860.800.84
    Low0.880.590.790.730.77
    All combined0.890.650.820.770.81
    NHigh0.770.890.730.910.86
    Intermediate0.830.770.590.920.79
    Low0.880.590.790.730.77
    All combined0.790.810.610.910.80
    MHigh0.870.880.910.830.87
    Intermediate0.960.730.830.930.86
    Low0.900.700.800.830.81
    All combined0.910.770.840.860.85
    • SE = sensitivity; SP = specificity; PPV = positive predictive value; NPV = negative predictive value; ACC = accuracy.

    • View popup
    TABLE 4.

    Overall Sensitivity and Specificity for Observer with High, Intermediate, or Low Experience

    Experience levelκSESPPPVNPVACC
    High0.690.870.820.830.860.85
    Intermediate0.660.910.750.790.890.83
    Low0.560.740.700.740.840.78
    • SE = sensitivity; SP = specificity; PPV = positive predictive value; NPV = negative predictive value; ACC = accuracy.

    • View popup
    TABLE 5.

    Agreement and Accuracy per Tumor Entity Irrespective of Reader Experience

    Tumor entityκSESPPPVNPVACC
    Colorectal0.680.840.850.830.860.85
    Genitourinary0.630.630.820.750.870.82
    Miscellaneous0.750.970.730.880.930.89
    Pancreas0.330.730.610.590.750.66
    Sarcoma0.740.960.770.830.950.87
    • SE = sensitivity; SP = specificity; PPV = positive predictive value; NPV = negative predictive value; ACC = accuracy.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Guide for Readers
    • Teaching Cases
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (7)
Journal of Nuclear Medicine
Vol. 64, Issue 7
July 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Riccardo Mei, Lukas Kessler, Kim M. Pabst, Manuel Weber, Christian Schmidkonz, Christoph Rischpler, Helle Damgaard Zacho, Thomas Hope, Sarah M. Schwarzenböck, Martin Allen-Auerbach, Louise Emmett, Justin Ferdinandus, Marcus Unterrainer, Benedikt M. Schaarschmidt, Lale Umutlu, Andrea Farolfi, Paolo Castellucci, Cristina Nanni, Silvi Telo, Stefano Fanti, Ken Herrmann, Wolfgang P. Fendler
Journal of Nuclear Medicine Jul 2023, 64 (7) 1043-1048; DOI: 10.2967/jnumed.122.265245

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Riccardo Mei, Lukas Kessler, Kim M. Pabst, Manuel Weber, Christian Schmidkonz, Christoph Rischpler, Helle Damgaard Zacho, Thomas Hope, Sarah M. Schwarzenböck, Martin Allen-Auerbach, Louise Emmett, Justin Ferdinandus, Marcus Unterrainer, Benedikt M. Schaarschmidt, Lale Umutlu, Andrea Farolfi, Paolo Castellucci, Cristina Nanni, Silvi Telo, Stefano Fanti, Ken Herrmann, Wolfgang P. Fendler
Journal of Nuclear Medicine Jul 2023, 64 (7) 1043-1048; DOI: 10.2967/jnumed.122.265245
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
  • Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • cancer imaging
  • FAPI
  • fibroblast activation protein
  • PET
  • interobserver agreement
SNMMI

© 2025 SNMMI

Powered by HighWire